News

(26 November 2020) - The Commission has adopted a Pharmaceutical Strategy for Europe to “ensure patients have access to innovative and affordable medicines and to support the competitiveness, innovative capacity and sustainability of the EU's pharmaceutical industry.”

Pharma
© European Commission

The Strategy will allow Europe to cover its pharmaceutical needs, including in times of crisis, through robust supply chains.

A key component of building a stronger European Health Union, the Strategy will help to establish a future-proof and crisis-resilient EU pharmaceutical system.

The Pharmaceutical Strategy for Europe marks the beginning of a process: its implementation includes an agenda of legislative and non-legislative actions which will be launched over the coming years.

More information

     
TOP